Indivisible Partners’s LENZ Therapeutics LENZ Stock Holding History

Indivisible Partners’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$65.9K	Buy	+17,158	New	+$85.4K	﹤0.01%	742

Other funds holding LENZ

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Owl Creek Wealth Partners Denver, Colorado $355M AUM

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Indivisible Partners's LENZ Position: Q3 2026 in Review

Indivisible Partners opened a new position in LENZ Therapeutics (LENZ) in Q3 2026: 17,158 shares worth $65.9K. The stake represents ﹤0.01% of the portfolio and ranks #742 among its holdings.

18 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

Indivisible Partners held 17,158 shares of LENZ Therapeutics worth $65.9K as of Q3 2026.
LENZ Therapeutics was a new Indivisible Partners position in Q3 2026.
LENZ Therapeutics made up ﹤0.01% of Indivisible Partners's portfolio in Q3 2026, its #742 holding.
18 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on Indivisible Partners's 13F filing for Q3 2026, filed 26 Oct 2026.